Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19.

MLA

Velu, Periyannan, et al. “Whole Genome Analysis and Homology Modeling of SARS-CoV-2 Indian Isolate Reveals Potent FDA Approved Drug Choice for Treating COVID-19.” Journal of Biomolecular Structure & Dynamics, vol. 41, no. 7, Apr. 2023, pp. 2772–88. EBSCOhost, https://doi.org/10.1080/07391102.2022.2038272.

APA

Velu, P., Rathinavel, T., Kumarasamy, S., Iqbal, M. N., Noor, H., Ikram, A., Rajamanickam, K., & Shanmugam, G. (2023). Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19. Journal of Biomolecular Structure & Dynamics, 41(7), 2772–2788. https://doi.org/10.1080/07391102.2022.2038272

Chicago

Velu, Periyannan, Thirumalaisamy Rathinavel, Suresh Kumarasamy, Muhammad Nasir Iqbal, Hasnat Noor, Ayesha Ikram, Karthika Rajamanickam, and Gnanendra Shanmugam. 2023. “Whole Genome Analysis and Homology Modeling of SARS-CoV-2 Indian Isolate Reveals Potent FDA Approved Drug Choice for Treating COVID-19.” Journal of Biomolecular Structure & Dynamics 41 (7): 2772–88. doi:10.1080/07391102.2022.2038272.